Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 11565 Triple Negative Breast Neoplasms 985 Neoplasms 665 Ovarian Neoplasms 577 Neoplasm Metastasis 522 Lung Neoplasms 503 Colorectal Neoplasms 503 Prostatic Neoplasms 488 Carcinoma, Non-Small-Cell Lung 469 Pancreatic Neoplasms 334 Melanoma 314 Stomach Neoplasms 303 Colonic Neoplasms 286 Breast Neoplasms, Male 259 Motor Activity 255 Carcinoma, Intraductal, Noninfiltrating 240 Head and Neck Neoplasms 229 Uterine Cervical Neoplasms 226 Endometrial Neoplasms 221 Carcinoma, Renal Cell 186 Sarcoma 179 Urinary Bladder Neoplasms 170 Squamous Cell Carcinoma of Head and Neck 168 Lymphedema 167 Esophageal Neoplasms 166 Breast Carcinoma In Situ 163 Brain Neoplasms 162 Fatigue 147 Carcinoma, Ovarian Epithelial 137 Breast Cancer Female 135

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡